Copyright
©The Author(s) 2002.
World J Gastroenterol. Feb 15, 2002; 8(1): 99-102
Published online Feb 15, 2002. doi: 10.3748/wjg.v8.i1.99
Published online Feb 15, 2002. doi: 10.3748/wjg.v8.i1.99
Figure 1 Restriction analysis of the strong positive recombinant phage clones.
M: λ/i I and i II; 1,2: Recombinant clones
Figure 2 Immunodoting of soluble MG7 scFv.
1: Perplasmic extracts from induced E.coli HB2151; 2: Supernatant from induced E.coli HB2151; 3: Perplasmic extracts from non-induced E.coli HB2151
Figure 3 Western blot of the molecular mass of soluble MG7 scFv.
M: Protein marker; 1: Perplasmic extracts from induced E.coli HB2151; 2: Supernatant from induced E.coli HB2151; 3: Perplasmic extracts from non-induced E.coli HB2151
Figure 4 Nucleotide sequence of MG7 scFv.
- Citation: Yu ZC, Ding J, Pan BR, Fan DM, Zhang XY. Expression and bioactivity identification of soluble MG7 scFv. World J Gastroenterol 2002; 8(1): 99-102
- URL: https://www.wjgnet.com/1007-9327/full/v8/i1/99.htm
- DOI: https://dx.doi.org/10.3748/wjg.v8.i1.99